Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) afflicts a significant percentage of the population; however, no effective treatments have yet been established because of the unsuitability of in vitro assays and animal experimental models. Here, we present an integrated-gut-liver-on-a-chip (iGLC) platform...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiandong, Hirai, Yoshikazu, Iida, Kei, Ito, Shinji, Trumm, Marika, Terada, Shiho, Sakai, Risako, Tsuchiya, Toshiyuki, Tabata, Osamu, Kamei, Ken-ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036655/
https://www.ncbi.nlm.nih.gov/pubmed/36959276
http://dx.doi.org/10.1038/s42003-023-04710-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036655/
https://www.ncbi.nlm.nih.gov/pubmed/36959276
http://dx.doi.org/10.1038/s42003-023-04710-8

Ejemplares similares